Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

NCT06238284 is registered in ClinicalTrials.gov with Chongqing University Cancer Hospital as lead sponsor.

NCT NCT06238284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06238284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
Lead sponsor
Chongqing University Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 26, 2024
Completion date
May 31, 2024
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, her2 expression, ovarian cancer